Flammer Martina M.D. 的 Form 4 申報
INSMED IncINSM,2026/1/6 申報
- 申報編號
- 0001796960-26-000002
- 申報時間
- 2026/1/6
- 交易日
- 2026/1/2-1/5
- 申報延遲
- 4 天
- 10b5-1 計畫
- 有勾選
這份申報列了 11 筆非衍生性交易、3 筆衍生性交易。公開市場賣出合計 $210.9 萬。交易後 4 天申報。
申報人
一份 Form 4 可以有好幾位申報人,例如本人與他控制的基金。各交易表上顯示的是第一位。
| 申報人 | 與公司的關係 |
|---|---|
| Flammer Martina M.D.CIK 0001796960 | 高階主管(醫療長) |
非衍生性證券(表 I)
普通股等股票的取得與處分,每一列是申報上的一筆。
| 交易日 | 證券 | 交易 | 股數 | 價格 | 金額 | 交易後持股 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2026/1/2 | Common Stock | A公司授予取得 | +5,998 | –F2 | – | 89,109 | 直接 | |
| 2026/1/2 | Common Stock | A公司授予取得 | +5,645 | –F2 | – | 94,754 | 直接 | |
| 2026/1/5 | Common Stock | M行使選擇權取得 | +4,358 | $19.74 | +$86,026.92 | 99,112 | 直接 | |
| 2026/1/5 | Common Stock | M行使選擇權取得 | +7,945 | $29.13 | +$231,437.85 | 107,057 | 直接 | |
| 2026/1/5 | Common Stock | S賣出處分 | −2,799 | $169.29F5 | −$473,842.71 | 104,258 | 直接 | |
| 2026/1/5 | Common Stock | S賣出處分 | −3,205 | $170.61F6 | −$546,805.05 | 101,053 | 直接 | |
| 2026/1/5 | Common Stock | S賣出處分 | −2,836 | $171.19F7 | −$485,494.84 | 98,217 | 直接 | |
| 2026/1/5 | Common Stock | S賣出處分 | −286 | $171.92 | −$49,169.12 | 97,931 | 直接 | |
| 2026/1/5 | Common Stock | S賣出處分 | −1,820 | $173.45F8 | −$315,679 | 96,111 | 直接 | |
| 2026/1/5 | Common Stock | S賣出處分 | −655 | $174.28F9 | −$114,153.4 | 95,456 | 直接 | |
| 2026/1/5 | Common Stock | S賣出處分 | −702 | $175.73F10 | −$123,362.46 | 94,754 | 直接 |
衍生性證券(表 II)
選擇權、認股權證、限制型股票單位等。股數是標的股票的股數;單價與金額是衍生證券本身的價格,交易後持有是衍生證券的單位數。
| 交易日 | 證券 | 交易 | 標的股數 | 單價 | 金額 | 交易後持有 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2026/1/2 | Common Stock | A公司授予取得 | +31,280 | $0.00 | $0 | 31,280 | 直接 | |
| 2026/1/5 | Common Stock | M行使選擇權處分 | −4,358 | $0.00 | $0 | 8,715 | 直接 | |
| 2026/1/5 | Common Stock | M行使選擇權處分 | −7,945 | $0.00 | $0 | 31,780 | 直接 |
附註與備註
本站收錄交易價格引用的附註、修正申報(Form 4/A)的全部附註,以及申報的備註。其他附註,例如間接持有的方式、交易計畫的細節,請看 SEC EDGAR 上的原文。
- F2
Each RSU was granted on January 2, 2026 for no consideration.
表 I 有 2 筆交易的價格引用這則附註。
- F5
This is the weighted average sales price representing 2,799 shares sold at prices ranging from $168.88 to $169.69 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
表 I 有 1 筆交易的價格引用這則附註。
- F6
This is the weighted average sales price representing 3,205 shares sold at prices ranging from $169.91 to $170.90 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
表 I 有 1 筆交易的價格引用這則附註。
- F7
This is the weighted average sales price representing 2,836 shares sold at prices ranging from $170.91 to $171.89 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
表 I 有 1 筆交易的價格引用這則附註。
- F8
This is the weighted average sales price representing 1,820 shares sold at prices ranging from $173.05 to $173.87 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
表 I 有 1 筆交易的價格引用這則附註。
- F9
This is the weighted average sales price representing 655 shares sold at prices ranging from $174.20 to $174.43 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
表 I 有 1 筆交易的價格引用這則附註。
- F10
This is the weighted average sales price representing 702 shares sold at prices ranging from $175.54 to $176.12 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
表 I 有 1 筆交易的價格引用這則附註。